Biotech

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Dipexium Pharmaceuticals Inc. (NASDAQ:DPRX) reported that Plx Pharma Inc. has picked up 4,414,270 of common stock as of 2017-01-03. The acquisition brings the aggregate amount owned Plx Pharma Inc. to a total of 4,414,270 representing...

If there's one space that has been a rollercoaster over the last few quarters, it's healthcare. With political inputs bubbling away under the surface, and the standard internal pressures on top, it's been a bit of a rollercoaster industry.  This, of course, is resulting in plenty of investment -...

We've been keeping a close on on Precision over he last month or so. With a government shakeup in the US dominating sentiment, and for a company that has such close ties to the government, that means a potential make or break period. Well, things aren't looking too bad. The...

With the 21st Century Cures Act dominating the media in the healthcare space, a number of entities are picking up strength. These companies range from the small scale juniors to the big names, and not just those at the cutting edge - industry infrastructure entities are also getting in...

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Landauer Inc (NYSE:LDR) reported that  Gilead Capital Lp has picked up 481,415 of common stock as of 2016-12-19. The acquisition brings the aggregate amount owned by Gilead Capital Lp to a total of 481,415 representing...